These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21801173)

  • 21. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.
    Tilz C; Resch R; Hofer T; Eggers C
    Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lacosamide for the treatment of epilepsy.
    de Biase S; Gigli GL; Valente M; Merlino G
    Expert Opin Drug Metab Toxicol; 2014 Mar; 10(3):459-68. PubMed ID: 24479852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
    Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
    Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rare cause of 2:1 atrioventricular block: carbamazepine.
    Celik IE; Akyel A; Colgecen M; Ozeke O
    Am J Emerg Med; 2015 Oct; 33(10):1541.e3-4. PubMed ID: 26306438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.
    Stöhr T; Kupferberg HJ; Stables JP; Choi D; Harris RH; Kohn H; Walton N; White HS
    Epilepsy Res; 2007 May; 74(2-3):147-54. PubMed ID: 17433624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrocardiographic characteristics of atrioventricular block induced by tilt testing.
    Zyśko D; Gajek J; Koźluk E; Mazurek W
    Europace; 2009 Feb; 11(2):225-30. PubMed ID: 18987129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lacosamide in Lennox-Gastaut syndrome: case report.
    Andrade-Machado R; Benjumea-Cuartas V; Jaramillo-Jimenez E
    Clin Neuropharmacol; 2012; 35(3):148-9. PubMed ID: 22592511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases.
    Liguori C; Romigi A; Placidi F; Sarpa MG; Mercuri NB; Izzi F
    Sleep Med; 2016 Jul; 23():121-122. PubMed ID: 26922622
    [No Abstract]   [Full Text] [Related]  

  • 29. Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis.
    Shibata M; Hoshino R; Shimizu C; Sato M; Furuta N; Ikeda Y
    BMC Neurol; 2021 Jun; 21(1):217. PubMed ID: 34102997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the novel antiepileptic drug lacosamide on the development of amygdala kindling in rats.
    Brandt C; Heile A; Potschka H; Stoehr T; Löscher W
    Epilepsia; 2006 Nov; 47(11):1803-9. PubMed ID: 17116018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lacosamide-induced rash.
    Koubeissi MZ; Vismer M; Ehrlich A
    Epileptic Disord; 2014 Sep; 16(3):380-3. PubMed ID: 25035958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac safety of lacosamide: the non-clinical perspective.
    Delaunois A; Colomar A; Depelchin BO; Cornet M
    Acta Neurol Scand; 2015 Nov; 132(5):337-45. PubMed ID: 25903789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lacosamide (vimpat). Prospects for clinical application].
    Rudakova IG; Vlasov PN; Lipatova LV; Voronkova KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):147-152. PubMed ID: 29053136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous lacosamide in seizure emergencies: Observations from a hospitalized in-patient adult population.
    d'Orsi G; Pascarella MG; Martino T; Carapelle E; Pacillo F; Di Claudio MT; Mancini D; Trivisano M; Avolio C; Specchio LM
    Seizure; 2016 Nov; 42():20-28. PubMed ID: 27693808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluctuation of lacosamide serum concentrations during the day and occurrence of adverse drug reactions--first clinical experience.
    Sattler A; Schaefer M; May TW; Rambeck B; Brandt C
    Epilepsy Res; 2011 Aug; 95(3):207-12. PubMed ID: 21543186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First case of lacosamide-induced psychosis.
    Chatzistefanidis D; Karvouni E; Kyritsis AP; Markoula S
    Clin Neuropharmacol; 2013; 36(1):27-8. PubMed ID: 23334072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: clinical article.
    Saria MG; Corle C; Hu J; Rudnick JD; Phuphanich S; Mrugala MM; Crew LK; Bota DA; Dan Fu B; Kim RY; Brown T; Feely H; Brechlin J; Brown BD; Drappatz J; Wen PY; Chen CC; Carter B; Lee JW; Kesari S
    J Neurosurg; 2013 Jun; 118(6):1183-7. PubMed ID: 23451905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug treatment of partial epilepsy.
    Mattson RH
    Adv Neurol; 1992; 57():643-50. PubMed ID: 1543086
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute or chronic use of lacosamide does not alter its distribution between serum and cerebrospinal fluid.
    Michelhaugh SK; Basha M; Rhoney DH; Shah AK; Mittal S
    Epilepsia; 2015 Nov; 56(11):1732-7. PubMed ID: 26249845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-dose oral lacosamide in refractory simple partial status epilepticus: case report and review.
    Hawkes MA; Fernández Suárez M; Ugarnes G; D'Giano C
    Clin Neuropharmacol; 2013; 36(4):138-40. PubMed ID: 23860347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.